Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON)

The Dermatologic Oncology Group of Japan Clinical Oncology Group has started a randomized phase III trial to confirm the superiority of adjuvant therapy with locoregional interferon beta in overall survival over surgery alone for patients with pathological stage II/III cutaneous melanoma (JCOG1309)....

Descripción completa

Detalles Bibliográficos
Autores principales: Namikawa, Kenjiro, Tsutsumida, Arata, Mizutani, Tomonori, Shibata, Taro, Takenouchi, Tatsuya, Yoshikawa, Shusuke, Kiyohara, Yoshio, Uchi, Hiroshi, Furue, Masutaka, Ogata, Dai, Tsuchida, Tetsuya, Yamazaki, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Clinical Trial Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896686/
https://www.ncbi.nlm.nih.gov/pubmed/29136453
http://dx.doi.org/10.1093/jjco/hyx063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896686/
https://www.ncbi.nlm.nih.gov/pubmed/29136453
http://dx.doi.org/10.1093/jjco/hyx063

Ejemplares similares